Artelo Biosciences, Inc. (ARTL) vs Silo Pharma, Inc. (SILO)

Artelo Biosciences, Inc. and Silo Pharma, Inc. are both Biotechnology companies. Artelo Biosciences, Inc. and Silo Pharma, Inc. are of similar size ($2.8M and $2.7M). Across the 11 metrics below, Silo Pharma, Inc. leads on 8 and Artelo Biosciences, Inc. on 3.

Valuation

Metric ARTL SILO Biotechnology median
P/E n/m n/m 7.88
P/S n/m 26.69 11.47
P/B 0.27 0.39 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.26 0.76 0.74
EV/Sales n/m (45.86) 10.73
Earnings yield (2,586.13%) (249.04%) (28.84%)
Free cash flow yield (923.67%) (204.00%) (23.03%)

Profitability

Metric ARTL SILO Biotechnology median
Gross margin 0.00% 11.81% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (705.71%) (91.23%) (57.72%)
Return on assets (234.30%) (70.96%) (49.22%)
Return on invested capital (865.85%) 0.00% 0.00%

Growth

Metric ARTL SILO Biotechnology median
Revenue growth (TTM) — 0.00% 5.64%
EPS growth (last fiscal year) 31.57% 57.98% —
Revenue growth, 5-year CAGR — 12.17% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARTL SILO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.00 5.36 4.73
Net debt to EBITDA 0.05 1.61 0.96

Dividend

Metric ARTL SILO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric ARTL SILO Biotechnology median
Market cap 2.71m 2.78m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack